ELADYNOS (Theramex Australia Pty Ltd)
Product name
ELADYNOS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
150 (175 working days)
Active ingredients
abaloparatide
Registration type
NCE/ NBE
Indication
ELADYNOS is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fracture.